Literature DB >> 7369203

Friedreich's ataxia with acute cardiomyopathy.

R A Berg, A M Kaplan, P B Jarrett, M E Molthan.   

Abstract

Friedreich's ataxia (FA) is a progressive, spinocerebellar degenerative disease. Onset is generally in the second decade of life, occurring as a neurologic degenerative process. Most, if not all, patients have an associated cardiomyopathy, which is frequently the cause of death. We studied two siblings who had FA with acute cardiomyopathy at 3 and 5 years of age, respectively, and in whom the classic nervous system signs developed, only later. The diagnosis of FA should be considered in patients of any age who have unexplained cardiomyopathy.

Entities:  

Mesh:

Year:  1980        PMID: 7369203     DOI: 10.1001/archpedi.1980.04490010044015

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  6 in total

1.  Anaesthesia for a patient with Friedreich's ataxia and cardiomyopathy.

Authors:  A M Campbell; G A Finley
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

2.  Biventricular function in Friedreich's ataxia: a radionuclide angiographic study.

Authors:  B Palagi; R Picozzi; F Casazza; M Possa; G Magri; O Zoccarato; E Graziano; F Ferrari; M Morpurgo
Journal:  Br Heart J       Date:  1988-06

3.  Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia.

Authors:  T N James; B W Cobbs; H C Coghlan; W C McCoy; C Fisch
Journal:  Br Heart J       Date:  1987-05

4.  Development of Wolff-Parkinson-White syndrome in a patient with Friedreich's ataxia.

Authors:  R N Baldwin; R J Lane
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

5.  Friedreich's ataxia. A clinical review with neurophysiological and echocardiographic findings.

Authors:  R S Ackroyd; J A Finnegan; S H Green
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

Review 6.  Echocardiography in neurological disorders.

Authors:  J P Lintermans
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.